Zhen Dong

445 total citations
11 papers, 318 citations indexed

About

Zhen Dong is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhen Dong has authored 11 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Zhen Dong's work include Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (3 papers) and Urinary Tract Infections Management (1 paper). Zhen Dong is often cited by papers focused on Circular RNAs in diseases (4 papers), MicroRNA in disease regulation (3 papers) and Urinary Tract Infections Management (1 paper). Zhen Dong collaborates with scholars based in China and United States. Zhen Dong's co-authors include Tao Huang, Conghui Han, Longmei Xu, Dawei Li, Xiaosong Chen, Ming Zhang, Xiaodong Yuan, Yao Xu, Dawei Li and Haoyu Wu and has published in prestigious journals such as Cell Death and Disease, Journal of Cellular and Molecular Medicine and International Immunopharmacology.

In The Last Decade

Zhen Dong

10 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhen Dong China 7 250 121 50 32 30 11 318
Conghui Han China 6 314 1.3× 158 1.3× 47 0.9× 56 1.8× 45 1.5× 12 385
Aiping Yin China 11 183 0.7× 97 0.8× 53 1.1× 43 1.3× 29 1.0× 26 302
Yizhi Cao China 12 298 1.2× 180 1.5× 23 0.5× 40 1.3× 15 0.5× 24 420
Ling Xie China 7 374 1.5× 267 2.2× 45 0.9× 90 2.8× 22 0.7× 8 509
Jianxin Qiu China 10 266 1.1× 51 0.4× 57 1.1× 34 1.1× 19 0.6× 15 370
Gaosi Xu China 8 177 0.7× 54 0.4× 73 1.5× 37 1.2× 11 0.4× 13 297
Veera Raghavan Thangapandi Germany 4 166 0.7× 120 1.0× 45 0.9× 35 1.1× 6 0.2× 7 280
Gaoyan Kuang China 10 243 1.0× 167 1.4× 14 0.3× 26 0.8× 14 0.5× 24 379
Yuying Kou China 11 191 0.8× 47 0.4× 30 0.6× 17 0.5× 11 0.4× 21 300

Countries citing papers authored by Zhen Dong

Since Specialization
Citations

This map shows the geographic impact of Zhen Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Dong more than expected).

Fields of papers citing papers by Zhen Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhen Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Dong. The network helps show where Zhen Dong may publish in the future.

Co-authorship network of co-authors of Zhen Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Zhen Dong. A scholar is included among the top collaborators of Zhen Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhen Dong. Zhen Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wang, Ziyu, Hongyang Wang, Qinghai Wang, et al.. (2024). Transcriptome analysis of anaerobic glycolysis effects on Jurkat T cell proliferation. Central European Journal of Immunology. 49(2). 194–202.
2.
Peng, Yi, Yatian Liu, Zhen Dong, et al.. (2023). LINC01376 promotes nasopharyngeal carcinoma tumorigenesis by competitively binding to the SP1/miR‐4757/IGF1 axis. IUBMB Life. 75(9). 702–716. 2 indexed citations
3.
Huang, Tao, Yang Gao, Yanwei Cao, Qinghai Wang, & Zhen Dong. (2022). Downregulation of mmu_circ_0000943 ameliorates renal ischemia reperfusion-triggered inflammation and oxidative stress via regulating mmu-miR-377-3p/Egr2 axis. International Immunopharmacology. 106. 108614–108614. 11 indexed citations
4.
Yang, Ruonan, Hongyang Wang, Qinghai Wang, et al.. (2022). Antitumor activity of RUNX3: Upregulation of E-cadherin and downregulation of the epithelial–mesenchymal transition in clear-cell renal cell carcinoma. Open Life Sciences. 17(1). 1579–1590. 1 indexed citations
5.
Wang, Qinghai, Kai Zhao, Guo Chen, et al.. (2021). Antibiotic Resistance and Virulence Genes of Escherichia coli Isolated from Patients with Urinary Tract Infections After Kidney Transplantation from Deceased Donors. Infection and Drug Resistance. Volume 14. 4039–4046. 6 indexed citations
6.
Huang, Tao, Yanwei Cao, Hongyang Wang, et al.. (2020). Circular RNA YAP1 acts as the sponge of microRNA‐21‐5p to secure HK‐2 cells from ischaemia/reperfusion‐induced injury. Journal of Cellular and Molecular Medicine. 24(8). 4707–4715. 30 indexed citations
9.
Wu, Haoyu, Tao Huang, Conghui Han, et al.. (2016). MiR-155 is Involved in Renal Ischemia-Reperfusion Injury via Direct Targeting of FoxO3a and Regulating Renal Tubular Cell Pyroptosis. Cellular Physiology and Biochemistry. 40(6). 1692–1705. 95 indexed citations
11.
Dong, Zhen, et al.. (2000). Membrane-type matrix metalloproteinases in mice intracorneally infected with Pseudomonas aeruginosa.. PubMed. 41(13). 4189–94. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026